-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.00231.13% Upside
Atossa Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Atossa Therapeutics, Inc.?
Atossa Therapeutics, Inc. has been rated by research analysts at Cantor Fitzgerald in the past 90 days.